课题基金 / 基金详情

Assessment of intracranial arterial collateralisation and venous microperfusion profile to predict infarct evolution in patients with early ischemic stroke and endovascular treatment using machine learning models

Assessment of intracranial arterial collateralisation and venous microperfusion profile to predict infarct evolution in patients with early ischemic stroke and endovascular treatment using machine learning models
使用机器学习模型评估颅内动脉侧支和静脉微灌注曲线,以预测早期缺血性中风患者的梗死进展和血管内治疗
批准号:
411621970
负责人:
Privatdozent Dr. Tobias Djamsched Faizy
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2019
资助国家:
德国
项目状态:
已结题
起止时间:
2018-12-31 至 2020-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
急性缺血性卒中(AIS)是指供血血管闭塞导致脑血流中断,随后依赖性脑组织缺氧。所有AIS治疗都试图通过溶解或清除阻塞大脑血流的凝块来恢复大脑的血流。静脉溶栓(tPA)已成为AIS的主要治疗方法超过20年。最近,一种称为血栓切除术的微创手术已被用于有效地清除大脑动脉中的血块。为了评估治疗方案,需要通过计算机断层扫描或磁共振成像检查脑组织及其血液循环。在医学影像学上,具有大量可挽救组织的患者通常显示称为颅内侧支(IC)的独特血管。在AIS期间,IC指的是血管通道的辅助网络,并且稳健的IC可以暂时保持血流到否则严重低灌注的脑区域,从而枢转地影响组织灌注的质量。因此,组织灌注由动脉血流入脑组织及其流出脑静脉来控制。近年来,大多数研究都集中在这个管道的动脉成分,但很少有人知道它的引流静脉侧。有人提出,确定AIS患者微血管系统的静脉部分内的血流可能更好地反映脑组织灌注的整体质量,因为它反映了通过脑组织后的血流。非常希望用医学成像来正确评估静脉微血管灌注状态,因为它保存了关于AIS期间大脑病理生理学的关键信息,并且可以作为治疗决策和患者临床结果的重要生物标志物。另一个关键但尚未解决的问题是,不同的医疗方法是否会对静脉微循环的稳健性和治疗结果产生显着影响。我们已经在斯坦福大学(美国)和汉堡-埃彭多夫大学医学中心(德国)之间建立了强有力的国际合作,并生成了目前650例接受tPA和血栓切除术治疗的AIS患者的最大前瞻性维护数据库之一。我们建议在血栓切除术治疗前使用多参数CT和MRI研究AIS患者的微血管灌注特征,重点关注静脉流出微循环。我们的目的是确定是否强大的皮质静脉微循环静脉溶栓的影响,以及这个参数是否影响病人的结果。我们的研究结果将增加对AIS期间脑微血管病理生理学的理解,我们努力为更好的个体化治疗选择和改善医疗护理做出贡献,以优化卒中患者的临床结局。
英文摘要
Acute ischemic stroke (AIS) is defined as disruption of blood flow to the brain caused by an occlusion of a supplying vessel and subsequent oxygen deficiency of the dependent brain tissue. All AIS treatments seek to restore blood flow to the brain by dissolving or removing the clot blocking blood flow to the brain. Intravenous thrombolysis (tPA) has been the predominant treatment of AIS for over two decades. More recently, a minimally-invasive surgery called thrombectomy has been used to effectively remove the blood clot from the artery in the brain. In order to evaluate treatment options, the brain tissue and its blood circulation need to be examined by means of computer tomography or magnetic resonance imaging. On medical imaging, patients with a large amount of salvageable tissue usually show distinctive vessels called intracranial collaterals (IC). During AIS, IC refer to a subsidiary network of vascular channels and robust IC may temporarily preserve blood flow to otherwise critically hypoperfused brain areas thus pivotally effecting the quality of tissue perfusion. Consequently, tissue perfusion is governed by the in-flow of arterial blood to the brain tissue and its outflow into the cerebral veins. In recent years, most studies have focused on the arterial component of this conduit, but very little is known about the draining venous side of it. It has been proposed that determining the blood flow within the venous part of the microvascular system of AIS patients may even better reflect the overall quality of brain tissue perfusion, as it reflects blood flow after passing the brain tissue. It would be highly desirable to properly assess the venous microvascular perfusion status with medical imaging, as it holds crucial information about brain’s pathophysiology during AIS and may serve as an important biomarker for treatment decision making and patients’ clinical outcome. Another critical, yet unresolved question is, whether distinct medical treatment approaches would have notable effects on the robustness of venous microcirculation and treatment outcome. We have established a strong international collaboration between Stanford University (USA) and the University Medical Center Hamburg-Eppendorf (Germany) and generated one of the largest prospectively maintained databases of currently 650 AIS patients treated with tPA and thrombectomy. We propose to investigate the microvascular perfusion profile in AIS patients with a focus on venous out-flow microcirculation using multi-parametric CT and MRI prior to thrombectomy treatment. We aim to determine whether robust cortical venous microcirculation is influenced by intravenous thrombolysis and whether this parameter influences patient outcome. Our results will augment the understanding of cerebral microvascular pathophysiology during AIS and we strive to contribute to a better individual treatment selection and improved medical care to optimize clinical outcome for stroke patients.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1161/strokeaha.120.032242
发表时间: 2021-05-01
期刊: STROKE
影响因子: 8.3
作者: [Faizy, Tobias D., Kabiri, Reza, Heit, Jeremy J.]
通讯作者: Heit, Jeremy J.
DOI: 10.1212/wnl.0000000000012106
发表时间: 2021-06-15
期刊: NEUROLOGY
影响因子: 9.9
作者: [Faizy, Tobias Djamsched, Kabiri, Reza, Heit, Jeremy J.]
通讯作者: Heit, Jeremy J.
海外基金